Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease.
Esben IversenThomas KallemoseMorten Baltzer HoulindAnne Kathrine BengaardJan Olof NehlinLine Jee Hartmann RasmussenHaakon SandholdtJuliette TavenierBo Feldt-RasmussenOve AndersenJesper Eugen-OlsenMorten Baltzer HoulindPublished in: Clinical kidney journal (2022)
A higher suPAR level was associated with accelerated eGFR decline among patients presenting to the emergency department, suggesting that routine suPAR measurements may have utility for the early detection of kidney disease.